SPY411.45-1.41 -0.34%
DIA337.53+0.74 0.22%
IXIC13,857.84-138.26 -0.99%

BRIEF-Prelude Therapeutics Announces Fourth Quarter And Full Year 2020 Financial Results And Provides Operational Update

· 03/16/2021 09:08
BRIEF-Prelude Therapeutics Announces Fourth Quarter And Full Year 2020 Financial Results And Provides Operational Update

- Prelude Therapeutics Inc PRLD.O:

  • PRELUDE THERAPEUTICS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS AND PROVIDES OPERATIONAL UPDATE

  • Q4 LOSS PER SHARE $0.45

  • Q4 EARNINGS PER SHARE ESTIMATE $-0.49 -- REFINITIV IBES DATA

  • CURRENT CASH & CASH EQUIVALENTS WILL BE SUFFICIENT TO FUND OPERATING EXPENSES & CAPITAL EXPENDITURE REQUIREMENTS INTO 2023

Source text for Eikon: ID:nGNX6BZGwR

Further company coverage: PRLD.O


((Reuters.Briefs@thomsonreuters.com;))